Advanz Pharma Corp. buy melinda
Start price
15.08.17
/
50%
€384.00
Target price
19.12.17
€450.00
Performance (%)
-45.31%
End price
19.12.17
€210.00
Summary
This prediction ended on 19.12.17 with a price of €210.00. Massive losses of -45.31% were the result for the BUY prediction by melinda. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Advanz Pharma Corp. | - | - | - | - |
| iShares Core DAX® | 1.432% | 1.580% | 13.249% | 61.139% |
| iShares Nasdaq 100 | 1.892% | -2.280% | 2.995% | 88.335% |
| iShares Nikkei 225® | -1.619% | 7.954% | 27.694% | 65.180% |
| iShares S&P 500 | 1.921% | -0.277% | 2.994% | 61.153% |
Comments by melinda for this prediction
In the thread Advanz Pharma Corp diskutieren
$
(Vom Mitglied beendet)
Stopped prediction by melinda for Advanz Pharma Corp.
Advanz Pharma Corp.
Start price
Target price
Perf. (%)
€346.37
15.08.17
15.08.17
€405.90
19.12.17
19.12.17
-45.31%
19.12.17
19.12.17
Advanz Pharma Corp.
Start price
Target price
Perf. (%)
€2,570.4
12.08.16
12.08.16
€3,264.0
13.02.17
13.02.17
-74.52%
13.02.17
13.02.17


